PapersFlow Research Brief
Amyotrophic Lateral Sclerosis Research
Research Guide
What is Amyotrophic Lateral Sclerosis Research?
Amyotrophic Lateral Sclerosis Research is the scientific study of molecular mechanisms, genetics, and pathology underlying ALS and related Frontotemporal Dementia, including TDP-43 pathology, FUS/TLS proteins, C9ORF72 mutations, motor neuron neurodegeneration, RNA processing disruptions, progranulin deficiency, and ubiquitin-positive inclusions.
The field encompasses 56,507 published works focused on ALS and FTD pathology. Key areas include genetic mutations like those in Cu/Zn superoxide dismutase and C9ORF72, as well as protein aggregates such as ubiquitinated TDP-43 in motor neurons. Diagnostic advancements feature revised criteria like El Escorial and ALSFRS-R scales for assessing disease progression.
Topic Hierarchy
Research Sub-Topics
TDP-43 Proteinopathy in ALS-FTD
This sub-topic investigates TDP-43 aggregation, nuclear clearance, and phosphorylation in sporadic ALS and FTD pathology. Researchers study phase separation, stress granule dynamics, and clearance pathways using iPS neuron models.
C9orf72 Hexanucleotide Repeat Expansions
This sub-topic examines GGGGCC repeat dipeptide toxicity, repeat-associated non-AUG translation, and nucleocytoplasmic transport defects in C9orf72 ALS-FTD. Researchers develop antisense oligonucleotides and CRISPR editing strategies.
FUS Mutations and RNA Processing Defects
This sub-topic focuses on FUS nuclear import failure, liquid-liquid phase separation, and splicing dysregulation from ALS mutations. Researchers use proteomics and droplet models to study stress responses.
SOD1 Mutations in Familial ALS
This sub-topic studies SOD1 misfolding, mitochondrial damage, and ER stress from >180 ALS mutations, using patient-derived models. Researchers target mutant SOD1 silencing and refolding chaperones.
Motor Neuron Selective Vulnerability
This sub-topic explores hyperexcitability, calcium dysregulation, and glia-neuron interactions causing motor neuron death sparing other neurons. Researchers use transcriptomics and optogenetics to identify resilience factors.
Why It Matters
ALS research has identified specific genetic causes, such as mutations in the Cu/Zn superoxide dismutase gene linked to 20% of familial ALS cases, enabling targeted genetic screening in families (Rosen et al., 1993). TDP-43 ubiquitination provides a pathological hallmark shared by ALS and frontotemporal lobar degeneration, aiding postmortem diagnosis and biomarker development (Neumann et al., 2006). C9ORF72 hexanucleotide repeat expansions account for chromosome 9p-linked ALS-FTD cases, informing genetic counseling and potential RNA-focused therapies (DeJesus-Hernandez et al., 2011; Renton et al., 2011). Diagnostic tools like the revised El Escorial criteria and ALSFRS-R scale standardize clinical trials and patient monitoring, with ALSFRS-R incorporating respiratory assessments to track functional decline (Brooks et al., 2000; Cedarbaum et al., 1999). Mouse models expressing human SOD1 mutations replicate motor neuron degeneration, supporting preclinical drug testing (Gurney et al., 1994).
Reading Guide
Where to Start
"Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis" (Rosen et al., 1993) identifies the first major ALS gene, providing foundational genetics before advancing to protein pathology and diagnostics.
Key Papers Explained
Rosen et al. (1993) established SOD1 mutations in familial ALS, extended by Gurney et al. (1994) in mouse models showing motor neuron loss. Neumann et al. (2006) revealed TDP-43 as the ubiquitinated protein in ALS-FTD inclusions, linking pathology. DeJesus-Hernandez et al. (2011) and Renton et al. (2011) independently confirmed C9ORF72 repeats as the chromosome 9p cause, converging genetics and pathology. Brooks et al. (2000) and Cedarbaum et al. (1999) provide diagnostic frameworks building on these discoveries.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues on TDP-43, FUS/TLS, and C9ORF72 mechanisms in motor neuron degeneration and RNA processing, as described in the core cluster. No recent preprints or news in the last 12 months indicate steady progress without new public breakthroughs.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Mutations in Cu/Zn superoxide dismutase gene are associated wi... | 1993 | Nature | 7.0K | ✕ |
| 2 | Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and ... | 2006 | Science | 6.4K | ✕ |
| 3 | El Escorial revisited: Revised criteria for the diagnosis of a... | 2000 | Amyotrophic Lateral Sc... | 5.3K | ✕ |
| 4 | Sensitivity of revised diagnostic criteria for the behavioural... | 2011 | Brain | 5.1K | ✓ |
| 5 | Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C... | 2011 | Neuron | 4.8K | ✓ |
| 6 | A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of C... | 2011 | Neuron | 4.4K | ✓ |
| 7 | New Multiple Sclerosis Phenotypic Classification | 2014 | European Neurology | 4.2K | ✕ |
| 8 | Motor Neuron Degeneration in Mice that Express a Human Cu,Zn S... | 1994 | Science | 4.1K | ✕ |
| 9 | Neurodegenerative diseases and oxidative stress | 2004 | Nature Reviews Drug Di... | 3.6K | ✕ |
| 10 | The ALSFRS-R: a revised ALS functional rating scale that incor... | 1999 | Journal of the Neurolo... | 3.2K | ✕ |
Frequently Asked Questions
What genetic mutation is associated with familial ALS?
Mutations in the Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis (Rosen et al., 1993). These mutations occur in about 20% of familial ALS patients. Mouse models expressing these human SOD1 mutations, such as glycine to alanine at position 93, show motor neuron degeneration despite retained enzyme activity (Gurney et al., 1994).
What is the role of TDP-43 in ALS and FTD?
Ubiquitinated TDP-43 forms inclusions that are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis (Neumann et al., 2006). These tau- and α-synuclein-negative aggregates are specific to these disorders. TDP-43 pathology links ALS and FTD pathologically.
How are C9ORF72 mutations involved in ALS-FTD?
An expanded GGGGCC hexanucleotide repeat in the noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS (DeJesus-Hernandez et al., 2011). A similar C9ORF72 repeat expansion is the cause of chromosome 9p21-linked ALS-FTD (Renton et al., 2011). These findings identify the most common genetic cause in these linked diseases.
What are the revised diagnostic criteria for ALS?
The El Escorial revisited criteria provide revised guidelines for diagnosing amyotrophic lateral sclerosis (Brooks et al., 2000). These criteria standardize clinical and electrophysiological assessments. They improve diagnostic accuracy across research and clinical settings.
What does the ALSFRS-R scale measure?
The ALSFRS-R is a revised ALS functional rating scale that incorporates assessments of respiratory function (Cedarbaum et al., 1999). It tracks disease progression in bulbar, spinal, and respiratory domains. This tool supports clinical trial endpoints and patient management.
What pathological features define ALS and FTD overlap?
Ubiquitin-positive inclusions containing TDP-43 are shared pathological features in ALS and frontotemporal lobar degeneration (Neumann et al., 2006). C9ORF72 repeat expansions link the genetic basis of chromosome 9p-associated cases (DeJesus-Hernandez et al., 2011). These features highlight molecular convergence in neurodegeneration.
Open Research Questions
- ? How do TDP-43 and FUS/TLS protein aggregates specifically trigger motor neuron death in ALS?
- ? What mechanisms underlie RNA processing defects from C9ORF72 hexanucleotide repeats in ALS-FTD?
- ? Can progranulin deficiency be therapeutically restored to halt ubiquitin-positive inclusion formation?
- ? How do SOD1 mutations induce selective neurodegeneration despite minimal impact on enzyme activity?
- ? What drives the genetic underpinnings of sporadic versus familial ALS cases?
Recent Trends
The field maintains 56,507 works with no specified 5-year growth rate.
Core focus persists on SOD1 mutations (Rosen et al., 1993; Gurney et al., 1994), TDP-43 pathology (Neumann et al., 2006), and C9ORF72 genetics (DeJesus-Hernandez et al., 2011; Renton et al., 2011).
Absence of recent preprints or news coverage in the last 12 months reflects consolidated knowledge without immediate shifts.
Research Amyotrophic Lateral Sclerosis Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Amyotrophic Lateral Sclerosis Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers